FridayOL

Game-Changer in HIV Prevention: FDA Approves First-Ever Twice-Yearly Injection

The Associated Press

Washington, D.C. – In a landmark decision poised to reshape the fight against HIV, the U.S. Food and Drug Administration (FDA) has approved Cabotegravir, the world's first injectable, long-acting HIV prevention medication administered just twice a ...Read more